March 25.2013Interim Report for the six months ended 31st December 2012 ...read more
Other news stories - Allergy Therapeutics granted US patent for sublingual administration of MPL adjuvant and vaccine antigens - Preliminary Results for the year ended 30 June 2012 - FDA Clinical Hold Lifted - Phase III Study Agreed - Fundraising announcement - Interim Results for the six months ended 31 December 2011
View all news
Allergy Therapeutics, Dominion Way, Worthing, West Sussex, BN14 8SA, United Kingdom
Tel +44 (0)1903 844 700
Click here to contact Allergy Therapeutics
View all images
